To explore the clinical effect of pancreatic duct stent placement in the treatment of acute biliary pancreatitis (ABP) patients.

Data of 200 ABP patients from January 2021 to January 2023 were retrospectively analyzed and divided into stent group and laparotomy group according to different surgical methods, with 100 patients in each group. The stent group was treated with pancreatic duct stent implantation, and the laparotomy group was treated with laparotomy. SPSS 26.0 software was used to process the data. Measurement data such as postoperative recovery, liver function and inflammatory response indexes before and 7 days after surgery were expressed as (), and independent sample t test was used; Postoperative complications and other statistical data were presented as [n (%)], χ² test was used, and curative effect was compared by Rank Sum test. P<0.05 was considered statistically significant.

The total effective rate of stent group (98.0%) was higher than that of laparotomy group (91.0%) (P<0.05). The time of abdominal pain relief, temperature return to normal, gastrointestinal ventilation time, feeding time, postoperative hospitalization time and postoperative complication rate in stent group were all lower than those in open group (P<0.05). The levels of aspartate aminotransferase (AST), total bilirubin (TBIL) and alanine aminotransferase (ALT) in 2 groups were lower than before surgery (P<0.05), and the stent group was lower than the open group (P<0.05). The levels of interleukin-8 (IL-8), C-reactive protein (CRP) and white blood cell count (WBC) in 2 groups were lower than those before surgery (P<0.05), and the stent group was lower than the open group (P<0.05).

Pancreatic duct stent implantation in the treatment of ABP has good short-term efficacy, can significantly reduce the incidence of complications, shorten the length of hospital stay, significantly improve the liver function of patients and alleviate inflammatory response.